TortsProf Blog

Editor: Christopher J. Robinette
Widener Commonwealth Law School

Thursday, October 19, 2006

More on Practice Guidelines

From the NYT story:

Three doctors at the National Institutes of Health have sharply criticized Eli Lilly for its efforts to promote the use of Xigris, an expensive treatment for patients with sepsis, an often deadly blood infection.

In an article published yesterday in The New England Journal of Medicine, the doctors wrote that Lilly — the nation’s sixth-largest drug maker — had manipulated treatment guidelines for sepsis patients to promote Xigris at the expense of older, cheaper and equally effective treatments.

Lilly says that it acted appropriately.

Current Affairs, Experts & Science, Products Liability | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference More on Practice Guidelines:


Eli Lilly is a big drug company that puts profits over patients.

They covered up findings that their Zyprexa has a TEN times greater risk of causing type 2 diabetes

Daniel Haszard Eli Lilly zyprexa drug caused my diabetes

Posted by: Daniel Haszard | Oct 19, 2006 8:48:40 AM

Post a comment